Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.53% | 4.36% | 10.26% | 8.61% | 8.04% |
| Total Depreciation and Amortization | -8.09% | -14.27% | -19.66% | -24.88% | -30.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,573.00% | 559.51% | -89.30% | -79.25% | -73.54% |
| Change in Net Operating Assets | -172.96% | -172.96% | -172.96% | -1,105.28% | -242.03% |
| Cash from Operations | 129.86% | 53.94% | -25.63% | -42.39% | -64.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -231.25% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,271.00% | -651.93% | -8.45% | -3.01% | 2.12% |
| Issuance of Common Stock | -- | -- | -- | -39.13% | 211.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 26.66% | -450.09% |
| Cash from Financing | -100.77% | -93.41% | -88.12% | -31.52% | 194.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.06% | -137.10% | -177.46% | -132.06% | 863.65% |